CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program

VQW-765Neutral
AI Analysis

Summary

Vanda Pharmaceuticals provided an update on the clinical development program for VQW-765. No specific details, outcomes, or timelines were disclosed in the announcement.

Importance:2/10
Sentiment:
0.00
clinical developmentprogram update
Related Companies

Read the original article

Published by yahoo_finance on October 14, 2026 9:00 PM

Read Original